InvestorsHub Logo
Followers 38
Posts 5557
Boards Moderated 0
Alias Born 02/25/2011

Re: Bad_Advice post# 34730

Thursday, 09/18/2014 4:59:23 PM

Thursday, September 18, 2014 4:59:23 PM

Post# of 426749
"become a Defendant in a 1st Amendment case"

because the FDA knows this strategy will be put into play once a CRL is received, the FDA may elect to delay issuing a CRL as long as possible hence thwarting the 1st Amendment claim. So who moves 1st? Does Amarin make 1st move by selling Anchor boldly before a CRL? - But no 1st Amendment rights are yet impaired because Amarin hasn't yet been told no yet on Anchor SNDA.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News